Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant – EurekAlert (press release)
Study explores use of checkpoint inhibitors after relapse from donor stem cell transplantEurekAlert (press release)ATLANTA – Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who re… Continue reading
